Becton Dickinson & Co (BDX) income statement
BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3018% above fair value
$215.42−1.05 (-0.49%)
Close on Nov 17, 2026Market cap $58.68BP/E 65.1Yield 1.93%
Becton Dickinson & Co income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 46.9%
- Operating margin
- 10.7%
- Net margin
- 4.0%
- Return on equity, FY2025
- 6.5%
Financial strength
- Current ratio
- 0.87
- Debt to equity
- 0.69
- Debt to assets
- 33.1%
- Cash to current liabilities
- 7.5%
Valuation
- P/E ratio
- 65.1
- Price to sales
- 2.52
- Price to book
- 2.40
- Dividend yield
- 1.93%
See a number that looks wrong?